Elevara Medicines Raises $70 Million Series A to Advance
Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and WeatherdenInnovative lead program, ELV001, in-licensed…
Cyclana Bio raises £5M to advance drug discovery for endometriosis
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, today announced the close of a £5M…
LassoESM accelerates discovery of therapeutic peptides
In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch.…
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 – Purespring…
AI-designed proteins revolutionize gene editing precision and safety
Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences…
Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis
Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates…
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Enhanced Genomics (‘Enhanced’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for…
Unlocking hidden soil microbes for new antibiotics
Most bacteria cannot be cultured in the lab-and that’s been bad news for medicine. Many of our frontline…
Mentavi study validates first fully digital diagnostic pathway for adult ADHD
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in…
Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
‘Resistin like molecule gamma’ punches holes into heart cells after myocardial infarction
Nina Kumowski, MD, of the Department of Radiology and Center for Systems Biology at Massachusetts General Hospital, is…
Nanostructures boost CRISPR delivery for genetic medicine
With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine.…